iLet ACE Pump
by Beta Bionics, Inc. 2 variants
510(k) K252770
iLet ACE Pump is a medical device (FDA Class II; FDA product code QFG, Alternate Controller Enabled Insulin Infusion Pump) made by Beta Bionics, Inc., cleared under FDA 510(k) K252770 on 29 Sep 2025, active as of 22 Oct 2026. 2 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
2 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK252770 | Date29 Sep 2025 | StatusActive |
Official records
- FDA 510(k) database K252770
From the FDA record
- Received by the FDA
- 2 Sep 2025
- FDA decision
- 29 Sep 2025 (Substantially Equivalent)
- FDA review time
- 27 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Ongoing Z-1996-2026
insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
-
- Ongoing Z-2513-2026
The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.
Timeline
- Recall initiated FDA recalls Z-2513-2026
- Cleared FDA 510(k) K252770
- Recall initiated FDA recalls Z-1996-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QFG
- Device class
- Class II
- Regulation
- 21 CFR Part 880.5730
- Advisory committee
- Clinical Chemistry
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QFG (Alternate Controller Enabled Insulin Infusion Pump).
- Tandem Mobi Insulin Pump with Interoperable Technology by Tandem Diabetes Care, Inc.
- DEKA ACE Pump System by Deka Research and Development
- MiniMed Flex pump by MEDTRONIC MINIMED, INC.
- t:slim Mobile Application, iOS 1014707 by Tandem Diabetes Care, Inc.
- Accu-Chek Solo Micropump System with Interoperable Technology by Roche Diabetes Care GmbH
- Omnipod 5 ACE Pump (Pod) by Insulet Corporation
- MiniMed 780G insulin pump by MEDTRONIC MINIMED, INC.
- twiist system by DEKA RESEARCH & DEVELOPMENT CORP.
- Omnipod 5 ACE Pump by Insulet Corporation
- Embecta Insulin Delivery System by embecta medical I LLC